PubMed:17006606 / 1353-1526 JSONTXT

{"project":"LitCoin-sentences","denotations":[{"id":"T8","span":{"begin":0,"end":173},"obj":"Sentence"}],"text":"Though FAS-670 polymorphisms did not show any significant difference, the proportion of subjects with IL1B-31TT (or IL1B-511CC) increased according to stage (trend P=0.019)."}

{"project":"LitCoin-entities","denotations":[{"id":"3433","span":{"begin":7,"end":10},"obj":"GeneOrGeneProduct"},{"id":"3434","span":{"begin":102,"end":106},"obj":"GeneOrGeneProduct"},{"id":"3435","span":{"begin":106,"end":111},"obj":"SequenceVariant"},{"id":"3436","span":{"begin":116,"end":120},"obj":"GeneOrGeneProduct"},{"id":"3437","span":{"begin":120,"end":126},"obj":"SequenceVariant"}],"attributes":[{"id":"A33","pred":"db_id","subj":"3433","obj":"NCBIGene:355"},{"id":"A34","pred":"db_id","subj":"3434","obj":"NCBIGene:3553"},{"id":"A35","pred":"db_id","subj":"3435","obj":"DBSNP:rs1143627"},{"id":"A36","pred":"db_id","subj":"3436","obj":"NCBIGene:3553"},{"id":"A37","pred":"db_id","subj":"3437","obj":"DBSNP:rs1143634"}],"namespaces":[{"prefix":"_base","uri":"https://w3id.org/biolink/vocab/"},{"prefix":"MESH","uri":"http://id.nlm.nih.gov/mesh/"},{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id="},{"prefix":"NCBIGene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"OMIM","uri":"https://www.omim.org/entry/"},{"prefix":"DBSNP","uri":"https://www.ncbi.nlm.nih.gov/snp/"}],"text":"Though FAS-670 polymorphisms did not show any significant difference, the proportion of subjects with IL1B-31TT (or IL1B-511CC) increased according to stage (trend P=0.019)."}

{"project":"LitCoin-SeqVar","denotations":[{"id":"T3","span":{"begin":106,"end":111},"obj":"SequenceVariant"},{"id":"T4","span":{"begin":120,"end":126},"obj":"SequenceVariant"}],"text":"Though FAS-670 polymorphisms did not show any significant difference, the proportion of subjects with IL1B-31TT (or IL1B-511CC) increased according to stage (trend P=0.019)."}

{"project":"LitCoin-GeneOrGeneProduct-v0","denotations":[{"id":"T30","span":{"begin":7,"end":10},"obj":"GeneOrGeneProduct"},{"id":"T31","span":{"begin":102,"end":106},"obj":"GeneOrGeneProduct"},{"id":"T32","span":{"begin":116,"end":120},"obj":"GeneOrGeneProduct"}],"text":"Though FAS-670 polymorphisms did not show any significant difference, the proportion of subjects with IL1B-31TT (or IL1B-511CC) increased according to stage (trend P=0.019)."}

{"project":"LitCoin-GeneOrGeneProduct-v2","denotations":[{"id":"T19","span":{"begin":102,"end":106},"obj":"GeneOrGeneProduct"},{"id":"T20","span":{"begin":116,"end":120},"obj":"GeneOrGeneProduct"}],"text":"Though FAS-670 polymorphisms did not show any significant difference, the proportion of subjects with IL1B-31TT (or IL1B-511CC) increased according to stage (trend P=0.019)."}

{"project":"LitCoin-GeneOrGeneProduct-v3","denotations":[{"id":"T13","span":{"begin":102,"end":106},"obj":"GeneOrGeneProduct"},{"id":"T14","span":{"begin":116,"end":120},"obj":"GeneOrGeneProduct"}],"text":"Though FAS-670 polymorphisms did not show any significant difference, the proportion of subjects with IL1B-31TT (or IL1B-511CC) increased according to stage (trend P=0.019)."}

{"project":"LitCoin_Mondo_095","denotations":[{"id":"T16","span":{"begin":7,"end":10},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A16","pred":"mondo_id","subj":"T16","obj":"0020708"},{"id":"A17","pred":"mondo_id","subj":"T16","obj":"0016011"}],"text":"Though FAS-670 polymorphisms did not show any significant difference, the proportion of subjects with IL1B-31TT (or IL1B-511CC) increased according to stage (trend P=0.019)."}

{"project":"LitCoin-Chemical-MeSH-CHEBI","denotations":[{"id":"T5","span":{"begin":7,"end":10},"obj":"ChemicalEntity"}],"attributes":[{"id":"A5","pred":"ID:","subj":"T5","obj":"http://purl.obolibrary.org/obo/CHEBI_76181"}],"text":"Though FAS-670 polymorphisms did not show any significant difference, the proportion of subjects with IL1B-31TT (or IL1B-511CC) increased according to stage (trend P=0.019)."}

{"project":"LitCoin-training-merged","denotations":[{"id":"T5","span":{"begin":7,"end":10},"obj":"ChemicalEntity"},{"id":"T14","span":{"begin":116,"end":120},"obj":"GeneOrGeneProduct"},{"id":"T13","span":{"begin":102,"end":106},"obj":"GeneOrGeneProduct"},{"id":"T51514","span":{"begin":120,"end":126},"obj":"SequenceVariant"},{"id":"T84638","span":{"begin":106,"end":111},"obj":"SequenceVariant"}],"attributes":[{"id":"A5","pred":"ID:","subj":"T5","obj":"http://purl.obolibrary.org/obo/CHEBI_76181"}],"text":"Though FAS-670 polymorphisms did not show any significant difference, the proportion of subjects with IL1B-31TT (or IL1B-511CC) increased according to stage (trend P=0.019)."}